Matches in SemOpenAlex for { <https://semopenalex.org/work/W1993694656> ?p ?o ?g. }
- W1993694656 endingPage "288" @default.
- W1993694656 startingPage "274" @default.
- W1993694656 abstract "Alkylating agents, such as streptozocin and dacarbazine, have been reported as active in neuroendocrine neoplasms (NENs). Temozolomide (TMZ) is an oral, potentially less toxic derivative of dacarbazine, which has shown activity both as a single agent and in combination with other drugs. Nevertheless, its role in NENs has not been well defined. Several retrospective and prospective phase I-II studies have been published describing its use in a variety of NENs. In a retrospective series, the combination of capecitabine and TMZ was reported to be associated with a particularly high tumour response in pancreatic NENs as a first-line treatment. Although in NENs, determination of the O<sup>6</sup>-methylguanine-DNA methyltransferase (MGMT) status has been suggested as a predictive biomarker of response, its role still remains investigational, awaiting validation along with the establishment of the optimal detection method. Metronomic schedules have been reported to potentially overcome MGMT-related drug resistance. Toxicity is manageable if well monitored. We reviewed the literature regarding pharmacological and clinical aspects of TMZ, focusing on specific settings of NENs, different schedules, toxicity and safety profiles, and potential predictive biomarkers of response." @default.
- W1993694656 created "2016-06-24" @default.
- W1993694656 creator A5017947396 @default.
- W1993694656 creator A5020435379 @default.
- W1993694656 creator A5024763432 @default.
- W1993694656 creator A5037557664 @default.
- W1993694656 creator A5040645190 @default.
- W1993694656 creator A5050426287 @default.
- W1993694656 creator A5066059020 @default.
- W1993694656 creator A5068503288 @default.
- W1993694656 creator A5071532685 @default.
- W1993694656 creator A5078823780 @default.
- W1993694656 creator A5086594420 @default.
- W1993694656 date "2015-01-01" @default.
- W1993694656 modified "2023-10-14" @default.
- W1993694656 title "Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects" @default.
- W1993694656 cites W130109868 @default.
- W1993694656 cites W1586545889 @default.
- W1993694656 cites W1590412378 @default.
- W1993694656 cites W1596193789 @default.
- W1993694656 cites W1765313028 @default.
- W1993694656 cites W1839519286 @default.
- W1993694656 cites W1948768651 @default.
- W1993694656 cites W1965579078 @default.
- W1993694656 cites W1967612457 @default.
- W1993694656 cites W1967817441 @default.
- W1993694656 cites W1971344938 @default.
- W1993694656 cites W1971921783 @default.
- W1993694656 cites W1974017236 @default.
- W1993694656 cites W1980163790 @default.
- W1993694656 cites W1985128675 @default.
- W1993694656 cites W1985537186 @default.
- W1993694656 cites W1990509102 @default.
- W1993694656 cites W1992615452 @default.
- W1993694656 cites W2006821285 @default.
- W1993694656 cites W2006830353 @default.
- W1993694656 cites W2007312936 @default.
- W1993694656 cites W2008997722 @default.
- W1993694656 cites W2011916383 @default.
- W1993694656 cites W2012856564 @default.
- W1993694656 cites W2015613797 @default.
- W1993694656 cites W2016615783 @default.
- W1993694656 cites W2020643908 @default.
- W1993694656 cites W2026218969 @default.
- W1993694656 cites W2031694870 @default.
- W1993694656 cites W2032494913 @default.
- W1993694656 cites W2033172867 @default.
- W1993694656 cites W2036085833 @default.
- W1993694656 cites W2036825872 @default.
- W1993694656 cites W2040830294 @default.
- W1993694656 cites W2052491055 @default.
- W1993694656 cites W2070965927 @default.
- W1993694656 cites W2079144528 @default.
- W1993694656 cites W2079786467 @default.
- W1993694656 cites W2081170063 @default.
- W1993694656 cites W2081457024 @default.
- W1993694656 cites W2082798082 @default.
- W1993694656 cites W2083682712 @default.
- W1993694656 cites W2090232354 @default.
- W1993694656 cites W2096915758 @default.
- W1993694656 cites W2098842245 @default.
- W1993694656 cites W2099880004 @default.
- W1993694656 cites W2100030097 @default.
- W1993694656 cites W2101266491 @default.
- W1993694656 cites W2105100844 @default.
- W1993694656 cites W2106763367 @default.
- W1993694656 cites W2107018012 @default.
- W1993694656 cites W2107966316 @default.
- W1993694656 cites W2115686439 @default.
- W1993694656 cites W2118672029 @default.
- W1993694656 cites W2121276929 @default.
- W1993694656 cites W2128879260 @default.
- W1993694656 cites W2129146015 @default.
- W1993694656 cites W2130735070 @default.
- W1993694656 cites W2130838589 @default.
- W1993694656 cites W2132550938 @default.
- W1993694656 cites W2135657152 @default.
- W1993694656 cites W2136785347 @default.
- W1993694656 cites W2137868544 @default.
- W1993694656 cites W2143281281 @default.
- W1993694656 cites W2149668080 @default.
- W1993694656 cites W2150308149 @default.
- W1993694656 cites W2158474413 @default.
- W1993694656 cites W2159009361 @default.
- W1993694656 cites W2161676563 @default.
- W1993694656 cites W2162830031 @default.
- W1993694656 cites W2163703503 @default.
- W1993694656 cites W2163941360 @default.
- W1993694656 cites W2166392962 @default.
- W1993694656 cites W2167713837 @default.
- W1993694656 cites W2168107554 @default.
- W1993694656 cites W2169965478 @default.
- W1993694656 cites W2171437910 @default.
- W1993694656 cites W2263248967 @default.
- W1993694656 cites W2339290868 @default.
- W1993694656 cites W2515795531 @default.
- W1993694656 cites W2589782464 @default.
- W1993694656 cites W2590094134 @default.